Aditi creates IP-based soln for bioinformatics

BANGALORE, INDIA: Software product and application development services provider Aditi Technologies today announced its foray into IP-led solutions by launching 'DNA PReDuST'.

This solution is deployed on top of Microsoft Biology Foundation (MBF), Microsoft’s recent bioinformatics platform offering, co-engineered by Aditi and Microsoft, said a press release.

Aditi said 'DNA PReDuST' or 'DNA Parallel Restriction Digestion using Suffix Trees', is an in-silico software solution targeted at scientists involved in bioinformatics, genomics and pharma research to identify appropriate slots in a DNA sequence at which it can be cleaved for in-vitro experiments.

Commenting on this development, Pankaj Jindal, president – Aditi Technologies, said, “IP-based solutions are exciting and firmly in-line with our vertical alignment strategy. This solution is a testimony of Aditi’s bioinformatics software engineering prowess and deep understanding of industry pain points.”

Welcoming the move, Simon Mercer, director of Health and Wellbeing – Microsoft, said “We at Microsoft are happy to see Aditi Technologies taking a lead in extending Microsoft Biology Foundation. This is a step towards unleashing the true potential of this framework and we offer our support and best wishes for the success of this effort”.

Aditi Technologies is a core member of Microsoft led BioIT Alliance - a cross-industry group working to integrate science and technology to accelerate bioinformatics and pharmaceutical research.